SEC Form 4/A · accession 0000886163-16-000222
LIGAND PHARMACEUTICALS INC · LGND
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
John W Kozarich
Director
Period of report
Sep 1, 2016
Accepted (ET)
Sep 9, 2016 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000886163
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Sep 1, 2016 | M | 1,666 | $45.60 | A | 40,983 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $45.60 | Sep 1, 2016 | M | 1,666 | D | Sep 27, 2007 | Sep 27, 2016 | Common Stock | 1,666 | 0 | D |
Explanation of responses
- F1This amendment is being filed to report the exercise of options prior to the previously reported open market sales on September 01, 2016.
- F2The transaction reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 01, 2015, in accordance with Rule 10b5-1.